Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
End Stage Mitochondrial Cardiomyopathy and Heart Transplantation Due to Biallelic Pathogenic C1QBP Variants.
Wilcox NS, Prenner SB, Cevasco M, Condit C, Goldstein A, Peterson JT, Tondi Resta I, Palmer M, Lal P, Owens AT, Pieretti J, Drivas TG, Reza N. Wilcox NS, et al. Among authors: pieretti j. Circ Genom Precis Med. 2022 Apr;15(2):e003559. doi: 10.1161/CIRCGEN.121.003559. Epub 2022 Feb 4. Circ Genom Precis Med. 2022. PMID: 35119291 Free PMC article. No abstract available.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Free article. Clinical Trial.
Deep learning approach for automated segmentation of myocardium using bone scintigraphy single-photon emission computed tomography/computed tomography in patients with suspected cardiac amyloidosis.
Bhattaru A, Rojulpote C, Vidula M, Duda J, Maclean MT, Swago S, Thompson E, Gee J, Pieretti J, Drachman B, Cohen A, Dorbala S, Bravo PE, Witschey WR. Bhattaru A, et al. Among authors: pieretti j. J Nucl Cardiol. 2024 Mar;33:101809. doi: 10.1016/j.nuclcard.2024.101809. Epub 2024 Feb 1. J Nucl Cardiol. 2024. PMID: 38307160
Nitric Oxide Plays a Dual Role in Cardiorenal Syndrome in Vitro Model.
Armentano GM, Pieretti JC, Falconi CA, Seabra AB, Carneiro-Ramos MS. Armentano GM, et al. Among authors: pieretti jc. Cell Physiol Biochem. 2024 Jan 22;58(1):33-48. doi: 10.33594/000000681. Cell Physiol Biochem. 2024. PMID: 38285930 Free article.
45 results